BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

464 related articles for article (PubMed ID: 24899704)

  • 21. Arginine methylation next to the PY-NLS modulates Transportin binding and nuclear import of FUS.
    Dormann D; Madl T; Valori CF; Bentmann E; Tahirovic S; Abou-Ajram C; Kremmer E; Ansorge O; Mackenzie IR; Neumann M; Haass C
    EMBO J; 2012 Nov; 31(22):4258-75. PubMed ID: 22968170
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An autopsy case of frontotemporal lobar degeneration with the appearance of fused in sarcoma inclusions (basophilic inclusion body disease) clinically presenting corticobasal syndrome.
    Matsumoto A; Suzuki H; Fukatsu R; Shimizu H; Suzuki Y; Hisanaga K
    Neuropathology; 2016 Feb; 36(1):77-87. PubMed ID: 26227957
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Targeting RACK1 to alleviate TDP-43 and FUS proteinopathy-mediated suppression of protein translation and neurodegeneration.
    Zhao B; Cowan CM; Coutts JA; Christy DD; Saraph A; Hsueh SCC; Plotkin SS; Mackenzie IR; Kaplan JM; Cashman NR
    Acta Neuropathol Commun; 2023 Dec; 11(1):200. PubMed ID: 38111057
    [TBL] [Abstract][Full Text] [Related]  

  • 24. TDP-43 and FUS: a nuclear affair.
    Dormann D; Haass C
    Trends Neurosci; 2011 Jul; 34(7):339-48. PubMed ID: 21700347
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Phosphorylation of C-terminal tyrosine residue 526 in FUS impairs its nuclear import.
    Darovic S; Prpar Mihevc S; Župunski V; Gunčar G; Štalekar M; Lee YB; Shaw CE; Rogelj B
    J Cell Sci; 2015 Nov; 128(22):4151-9. PubMed ID: 26403203
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gene expression responses to FUS, EWS, and TAF15 reduction and stress granule sequestration analyses identifies FET-protein non-redundant functions.
    Blechingberg J; Luo Y; Bolund L; Damgaard CK; Nielsen AL
    PLoS One; 2012; 7(9):e46251. PubMed ID: 23049996
    [TBL] [Abstract][Full Text] [Related]  

  • 27. ALS-associated fused in sarcoma (FUS) mutations disrupt Transportin-mediated nuclear import.
    Dormann D; Rodde R; Edbauer D; Bentmann E; Fischer I; Hruscha A; Than ME; Mackenzie IR; Capell A; Schmid B; Neumann M; Haass C
    EMBO J; 2010 Aug; 29(16):2841-57. PubMed ID: 20606625
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular and behavioural abnormalities in the FUS-tg mice mimic frontotemporal lobar degeneration: Effects of old and new anti-inflammatory therapies.
    de Munter J; Babaevskaya D; Wolters EC; Pavlov D; Lysikova E; V Kalueff A; Gorlova A; Oplatchikova M; Pomytkin IA; Proshin A; Umriukhin A; Lesch KP; Strekalova T
    J Cell Mol Med; 2020 Sep; 24(17):10251-10257. PubMed ID: 32667139
    [TBL] [Abstract][Full Text] [Related]  

  • 29. TAF15 amyloid filaments in frontotemporal lobar degeneration.
    Tetter S; Arseni D; Murzin AG; Buhidma Y; Peak-Chew SY; Garringer HJ; Newell KL; Vidal R; Apostolova LG; Lashley T; Ghetti B; Ryskeldi-Falcon B
    Nature; 2024 Jan; 625(7994):345-351. PubMed ID: 38057661
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Localization of fused in sarcoma (FUS) protein to the post-synaptic density in the brain.
    Aoki N; Higashi S; Kawakami I; Kobayashi Z; Hosokawa M; Katsuse O; Togo T; Hirayasu Y; Akiyama H
    Acta Neuropathol; 2012 Sep; 124(3):383-94. PubMed ID: 22526020
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of Fused in sarcoma mutations in mice recapitulates the neuropathology of FUS proteinopathies and provides insight into disease pathogenesis.
    Verbeeck C; Deng Q; Dejesus-Hernandez M; Taylor G; Ceballos-Diaz C; Kocerha J; Golde T; Das P; Rademakers R; Dickson DW; Kukar T
    Mol Neurodegener; 2012 Oct; 7():53. PubMed ID: 23046583
    [TBL] [Abstract][Full Text] [Related]  

  • 32. How do the RNA-binding proteins TDP-43 and FUS relate to amyotrophic lateral sclerosis and frontotemporal degeneration, and to each other?
    Baloh RH
    Curr Opin Neurol; 2012 Dec; 25(6):701-7. PubMed ID: 23041957
    [TBL] [Abstract][Full Text] [Related]  

  • 33. NPM-hMLF1 fusion protein suppresses defects of a Drosophila FTLD model expressing the human FUS gene.
    Yamamoto I; Azuma Y; Kushimura Y; Yoshida H; Mizuta I; Mizuno T; Ueyama M; Nagai Y; Tokuda T; Yamaguchi M
    Sci Rep; 2018 Jul; 8(1):11291. PubMed ID: 30050143
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization and expression analysis in the developing embryonic brain of the porcine FET family: FUS, EWS, and TAF15.
    Blechingberg J; Holm IE; Nielsen AL
    Gene; 2012 Feb; 493(1):27-35. PubMed ID: 22143032
    [TBL] [Abstract][Full Text] [Related]  

  • 35. O-GlcNAc glycosylation stoichiometry of the FET protein family: only EWS is glycosylated with a high stoichiometry.
    Kamemura K
    Biosci Biotechnol Biochem; 2017 Mar; 81(3):541-546. PubMed ID: 27903134
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inclusions in frontotemporal lobar degeneration with TDP-43 proteinopathy (FTLD-TDP) and amyotrophic lateral sclerosis (ALS), but not FTLD with FUS proteinopathy (FTLD-FUS), have properties of amyloid.
    Bigio EH; Wu JY; Deng HX; Bit-Ivan EN; Mao Q; Ganti R; Peterson M; Siddique N; Geula C; Siddique T; Mesulam M
    Acta Neuropathol; 2013 Mar; 125(3):463-5. PubMed ID: 23378033
    [No Abstract]   [Full Text] [Related]  

  • 37. Pathological features of FTLD-FUS in a Japanese population: analyses of nine cases.
    Kobayashi Z; Kawakami I; Arai T; Yokota O; Tsuchiya K; Kondo H; Shimomura Y; Haga C; Aoki N; Hasegawa M; Hosokawa M; Oshima K; Niizato K; Ishizu H; Terada S; Onaya M; Ikeda M; Oyanagi K; Nakano I; Murayama S; Akiyama H; Mizusawa H
    J Neurol Sci; 2013 Dec; 335(1-2):89-95. PubMed ID: 24050818
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular determinants and genetic modifiers of aggregation and toxicity for the ALS disease protein FUS/TLS.
    Sun Z; Diaz Z; Fang X; Hart MP; Chesi A; Shorter J; Gitler AD
    PLoS Biol; 2011 Apr; 9(4):e1000614. PubMed ID: 21541367
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Atypical FTLD-FUS associated with ALS-TDP: a case report.
    Kobayashi Z; Arai T; Yokota O; Tsuchiya K; Hosokawa M; Oshima K; Niizato K; Akiyama H; Mizusawa H
    Neuropathology; 2013 Feb; 33(1):83-6. PubMed ID: 22640227
    [TBL] [Abstract][Full Text] [Related]  

  • 40. RNA-binding ability of FUS regulates neurodegeneration, cytoplasmic mislocalization and incorporation into stress granules associated with FUS carrying ALS-linked mutations.
    Daigle JG; Lanson NA; Smith RB; Casci I; Maltare A; Monaghan J; Nichols CD; Kryndushkin D; Shewmaker F; Pandey UB
    Hum Mol Genet; 2013 Mar; 22(6):1193-205. PubMed ID: 23257289
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.